Reference

AMET works diligently to keep the following information updated with the most current medical aesthetic news.  This information has been supplied by numerous sources. AMET is not affiliated with any such sources, and the information provided does not reflect the views of AMET.  The function of this page is to simply provide information, and AMET does not accept responsibility or liability for any views/claims/rumors/errors that appears herein.  

3/20/2012
Injunction Throws a Wrinkle in Merz's Plan to Launch Xeomin
About a week before Merz was slated to introduce Xeomin at a major medical meeting, Botox manufacturer Allergan has won an immediate injunction blocking the company from selling this product, which is a Botox competitor.The injunction prohibits Merz from selling or soliciting purchases of its Botox alternative, Xeomin, in the facial aesthetics market for 10 months
Injunction Throws a Wrinkle in Merz's Plan to Launch Xeomin

About a week before Merz was slated to introduce Xeomin at a major medical meeting, Botox manufacturer Allergan has won an immediate injunction blocking the company from selling this product, which is a Botox competitor.The injunction prohibits Merz from selling or soliciting purchases of its Botox alternative, Xeomin, in the facial aesthetics market for 10 months

http://www.plasticsurgerypractice.com/eReport/2012...

back to reference main